T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...

T-DXd significantly improved IDFS and reduced the risk of invasive disease or death by 53% compared to T-DM1 in high-risk, HER2-positive breast cancer patients. The trial demonstrated superior ...

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

That’s where the right reusable water bottle becomes more than just a sustainable accessory—it’s your first line of defense against these microplastics. “Stainless steel and glass are very safe,” says ...

Immune checkpoint inhibitors (ICI) have had a dramatic effect on cancer outcomes with their use increasing as indications expand. Despite impressive efficacy across a range of tumour types, their role ...

With only 22% of seniors at or above NAEP Proficient and 45% below Basic, the nation must pivot from a singular focus on the top quartile to engaging all students in meaningful, real-world mathematics ...

The KwaZulu-Natal Department of Education announces its readiness for the 2025 Grade 12 final examinations, highlighting a ...

Cover Image Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies ...

Investors with an interest in Business - Services stocks have likely encountered both Rentokil Initial PLC (RTO) and Thomson Reuters (TRI). But which of these two stocks is more attractive to value ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...